Portage Biotech Inc
NASDAQ:PRTG

Watchlist Manager
Portage Biotech Inc Logo
Portage Biotech Inc
NASDAQ:PRTG
Watchlist
Price: 4.22 USD 0.48% Market Closed
Market Cap: 4.4m USD
Have any thoughts about
Portage Biotech Inc?
Write Note

Portage Biotech Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Portage Biotech Inc
Cash from Operating Activities Peer Comparison

Comparables:
B
DRUG
RPTX
AUPH
COV
EDT

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Portage Biotech Inc
NASDAQ:PRTG
Cash from Operating Activities
-$12.5m
CAGR 3-Years
-34%
CAGR 5-Years
-50%
CAGR 10-Years
-17%
B
Bright Minds Biosciences Inc
CNSX:DRUG
Cash from Operating Activities
-CA$7m
CAGR 3-Years
-190%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Cash from Operating Activities
-$127.2m
CAGR 3-Years
-176%
CAGR 5-Years
-59%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Cash from Operating Activities
-$1.7m
CAGR 3-Years
76%
CAGR 5-Years
49%
CAGR 10-Years
19%
Covalon Technologies Ltd
XTSX:COV
Cash from Operating Activities
CA$1.2m
CAGR 3-Years
45%
CAGR 5-Years
N/A
CAGR 10-Years
-9%
Spectral Medical Inc
TSX:EDT
Cash from Operating Activities
-CA$8.5m
CAGR 3-Years
-2%
CAGR 5-Years
-42%
CAGR 10-Years
1%

See Also

What is Portage Biotech Inc's Cash from Operating Activities?
Cash from Operating Activities
-12.5m USD

Based on the financial report for Jun 30, 2024, Portage Biotech Inc's Cash from Operating Activities amounts to -12.5m USD.

What is Portage Biotech Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-17%

Over the last year, the Cash from Operating Activities growth was 6%. The average annual Cash from Operating Activities growth rates for Portage Biotech Inc have been -34% over the past three years , -50% over the past five years , and -17% over the past ten years .

Back to Top